These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 15488326

  • 1. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
    Kim HD, Kong FK, Cao Y, Lewis TL, Kim H, Tang DC, Fukuchi K.
    Neurosci Lett; 2004 Nov 11; 370(2-3):218-23. PubMed ID: 15488326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
    Zou J, Yao Z, Zhang G, Wang H, Xu J, Yew DT, Forster EL.
    J Neurol Sci; 2008 Sep 15; 272(1-2):87-98. PubMed ID: 18571202
    [Abstract] [Full Text] [Related]

  • 4. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease.
    Kim HD, Maxwell JA, Kong FK, Tang DC, Fukuchi K.
    Biochem Biophys Res Commun; 2005 Oct 14; 336(1):84-92. PubMed ID: 16126169
    [Abstract] [Full Text] [Related]

  • 5. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
    Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ.
    Ann Neurol; 2000 Oct 14; 48(4):567-79. PubMed ID: 11026440
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD, Jin JJ, Maxwell JA, Fukuchi K.
    Immunol Lett; 2007 Sep 15; 112(1):30-8. PubMed ID: 17686533
    [Abstract] [Full Text] [Related]

  • 8. Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine.
    DaSilva KA, Brown ME, McLaurin J.
    Vaccine; 2009 Feb 25; 27(9):1365-76. PubMed ID: 19150380
    [Abstract] [Full Text] [Related]

  • 9. Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice.
    Sohn JH, So JO, Kim H, Nam EJ, Ha HJ, Kim YH, Mook-Jung I.
    Biochem Biophys Res Commun; 2007 Sep 28; 361(3):800-4. PubMed ID: 17678618
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
    Zota V, Nemirovsky A, Baron R, Fisher Y, Selkoe DJ, Altmann DM, Weiner HL, Monsonego A.
    J Immunol; 2009 Sep 01; 183(5):3522-30. PubMed ID: 19675171
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V, Steinitz M.
    Autoimmun Rev; 2006 Jan 01; 5(1):33-9. PubMed ID: 16338209
    [Abstract] [Full Text] [Related]

  • 13. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
    Bacher M, Depboylu C, Du Y, Noelker C, Oertel WH, Behr T, Henriksen G, Behe M, Dodel R.
    Neurosci Lett; 2009 Jan 16; 449(3):240-5. PubMed ID: 18786612
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
    Chauhan NB, Siegel GJ.
    J Neurosci Res; 2002 Jul 01; 69(1):10-23. PubMed ID: 12111811
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy for Alzheimer's disease.
    McGeer PL, McGeer E.
    Sci Aging Knowledge Environ; 2004 Jul 07; 2004(27):pe29. PubMed ID: 15243154
    [Abstract] [Full Text] [Related]

  • 17. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I, Arbel M, Solomon B.
    Neurodegener Dis; 2007 Jul 07; 4(5):392-402. PubMed ID: 17536186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid beta (1-42) plus CpG oligodeoxynucleotides in aged rats.
    Subramanian S, Divya Shree AN.
    Neurosci Lett; 2008 May 09; 436(2):219-22. PubMed ID: 18394801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.